$1.030
+0.020 (+1.98%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting LCTX is Buy.
Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 0.99, while Lineage Cell Therapeutics Inc (LCTX) share price is $—, making it Buy.
Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.02, while Lineage Cell Therapeutics Inc (LCTX) share price is $—, making it Buy.
Technical Analysis for LCTX
AI Technical LCTXAs of 2026-11-03, the technical board for Lineage Cell Therapeutics Inc (LCTX) reads buy: 7 indicators are flashing buy, 3 are indicating sell, and 3 are neutral. Price at $1.03 sits below the 200-day moving averages and above the 5-day, 10-day, 20-day and 60-day.
Momentum readings: RSI stands at 55.271, MACD stands at 0.00717 (Buy), Stochastic %K stands at 69.29, Stochastic %D stands at 69.492 and CCI stands at 124.475 (Sell).
LCTX trades above the 60-day SMA (1.02) and below the 200-day SMA (1.32). Immediate resistance sits at Classic R1 1.07, then R2 1.13. Support sits at Classic S1 0.95, then S2 0.88.
Lineage Cell Therapeutics Inc (LCTX) Support & Resistance Level
Lineage Cell Therapeutics Inc (LCTX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 55.271 |
| STOCHk_14_3_3 | 69.290 |
| STOCHd_14_3_3 | 69.492 |
| CCI_20 | 124.475 |
| AO_5_34 | 0.040 |
| MOM_10 | 0.079 |
| MACD_12_26_9 | 0.007 |
Lineage Cell Therapeutics Inc (LCTX) Relative Strength Index (RSI_14) is 55.271, creating a Neutral signal.
Lineage Cell Therapeutics Inc (LCTX) Stochastic %K is 69.290, creating a Neutral signal.
Lineage Cell Therapeutics Inc (LCTX) Stochastic %D is 69.492, creating a Neutral signal.
Lineage Cell Therapeutics Inc (LCTX) CCI_20 is 124.475, creating a Sell signal.
Lineage Cell Therapeutics Inc (LCTX) Awesome Oscillator (AO) is 0.040, creating a Buy signal.
Lineage Cell Therapeutics Inc (LCTX) Momentum (MOM) is 0.079, creating a Buy signal.
Lineage Cell Therapeutics Inc (LCTX) Moving Average Convergence Divergence (MACD) is 0.007, creating a Buy signal.
Lineage Cell Therapeutics Inc (LCTX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.016 | Buy |
| MA_10 | 1.013 | Buy |
| MA_20 | 0.989 | Buy |
| MA_60 | 1.023 | Buy |
| MA_200 | 1.317 | Sell |
| MA_250 | 1.398 | Sell |
Lineage Cell Therapeutics Inc (LCTX) 5-Day simple moving average is 1.016, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Buy.
Lineage Cell Therapeutics Inc (LCTX) 10-Day simple moving average is 1.013, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Buy.
Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 0.989, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Buy.
Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.023, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Buy.
Lineage Cell Therapeutics Inc (LCTX) 200-Day simple moving average is 1.317, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Sell.
Lineage Cell Therapeutics Inc (LCTX) 250-Day simple moving average is 1.398, while Lineage Cell Therapeutics Inc (LCTX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.